19"/> 19"/>
Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
 

Drug Development

مضادات الفيروسات التي لم تكن يوما كذلك: نتائج مضللة كانت نِتاج إعادة توجيه أدوية مُرخصة لمعالجة الكوفيد 19

فئة كاملة من المركبات تُعطل الخلية بدلا من ايقاف الفيروس

by Leigh Krietsch Boerner
July 12, 2021 | A version of this story appeared in Volume 99, Issue 25

Article:

This article has been sent to the following recipient: